Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(8)
•••
wofats
X
View Profile
View Bullboard History
Post by
wofats
on Feb 04, 2024 4:02pm
From La Presse
An institutional from Saint-Bruno rises in shareholding PHOTO ANDR PICHETTE, LA PRESSE ARCHIVES Knight's stock continues to trade near its floor price. The stock closed
...more
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on Feb 03, 2024 12:59pm
RE:Armoyan
The 81,793 were only the shares traded on the TSE 250.000 total shares were traded for that day on all the exchanges Stockwatch gives the toal traded for stock trades
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 25, 2024 7:30am
New Press Release - Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203
MONTREAL, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal"), granting...
read article.
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Jan 24, 2024 1:04pm
RE:As NCIB tapers off...
Yes... we'll see how it goes. Always hard to predict price movements. It's also possible they keep on buying, right? Lots of positive momentum in my opinion as well. --- Samira on growth
...more
(3)
•••
porksniffer
X
View Profile
View Bullboard History
Post by
porksniffer
on Jan 24, 2024 9:46am
The ever present ghost of Meir
Always love to read and visit the bagholders here. Good for a laugh. Ten years on same cast of charachters with their predictions and hopes for Palladin glory. Meir told you paragrapgh by paragraph
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Post by
gudisgood
on Jan 24, 2024 8:11am
Promotions
A few promotions / title changes within the Executives at Knight. Monica Percario Ms. Percario joined Knight as Global VP of Scientific Affairs in August 2021 and appointed to Global VP Regulatory
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jan 23, 2024 9:23am
Solid results fr J&J incl good pharma growth & medical devic
https://www.cnbc.com/2024/01/23/johnson-johnson-jnj-earnings-q4-2023.html?__source=iosappshare%7Ccom.google.chrome.ios.ShareExtension
(152)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Jan 21, 2024 6:44pm
RE:RE:RE:Jan 3rd Share Repurchase… 2,999,497
I have been checking SEDI and there is virtually nothing now. I am happy they went hard at the buybacks. My hope is that they make some big moves in 2024 in both capital deployment and operating
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Jan 07, 2024 6:49am
RE:Jan 3rd Share Repurchase… 2,999,497
We will still see growth from the current portfolio (plus the couple of launches) this year. Hopefully the Ambisome orders continue coming in as well. And for 2025, there are many launches scheduled
...more
(152)
•••
longrun86
X
View Profile
View Bullboard History
Post by
longrun86
on Jan 06, 2024 2:07pm
Jan 3rd Share Repurchase… 2,999,497
Talk about putting their money where their mouth is with a $15.3m purchase! I am expecting big things from Knight this year from a business performance perspective. On a side note, I am very curious
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jan 04, 2024 1:00pm
Great to see another product LAUNCH TODAY!!
Imvexxy launched. More products to end users.
(1)
•••
Michel1234
X
View Profile
View Bullboard History
Post by
Michel1234
on Jan 04, 2024 10:10am
NCIB
Knight repurchase for cancellation on December 21: 2,999,497 shares at @5,10$. Just speculation but it could be the final portion of the shares owned by Medison? The extract below was in a press
...more
(1)
•••
Stockoman1
X
View Profile
View Bullboard History
Post by
Stockoman1
on Dec 22, 2023 9:18am
Interesting things going on....
https://www.theglobeandmail.com/investing/markets/stocks/GUD-T/pressreleases/22829458/
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Dec 19, 2023 11:00am
Qelbree - ADHD - huge opportunity
ADHD - more & more kids are affected by this & stand to benefit from a great therapeutic
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >